- Home
- ACIU vs IONR Comparison
ACIU vs IONR Comparison
Compare ACIU & IONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- IONR
- Stock Information
- Founded
- ACIU 2003
- IONR 2001
- Country
- ACIU Switzerland
- IONR Australia
- Employees
- ACIU N/A
- IONR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- IONR
- Sector
- ACIU Health Care
- IONR
- Exchange
- ACIU Nasdaq
- IONR Nasdaq
- Market Cap
- ACIU 294.9M
- IONR 319.2M
- IPO Year
- ACIU 2016
- IONR N/A
- Fundamental
- Price
- ACIU $2.65
- IONR $5.44
- Analyst Decision
- ACIU Strong Buy
- IONR
- Analyst Count
- ACIU 2
- IONR 0
- Target Price
- ACIU $12.00
- IONR N/A
- AVG Volume (30 Days)
- ACIU 147.0K
- IONR 59.2K
- Earning Date
- ACIU 03-13-2025
- IONR 01-01-0001
- Dividend Yield
- ACIU N/A
- IONR N/A
- EPS Growth
- ACIU N/A
- IONR N/A
- EPS
- ACIU N/A
- IONR N/A
- Revenue
- ACIU $48,505,404.00
- IONR N/A
- Revenue This Year
- ACIU $86.72
- IONR N/A
- Revenue Next Year
- ACIU $118.28
- IONR N/A
- P/E Ratio
- ACIU N/A
- IONR N/A
- Revenue Growth
- ACIU 4097200.00
- IONR N/A
- 52 Week Low
- ACIU $2.25
- IONR $2.90
- 52 Week High
- ACIU $4.98
- IONR $9.35
- Technical
- Relative Strength Index (RSI)
- ACIU 39.10
- IONR 69.28
- Support Level
- ACIU $2.56
- IONR $4.05
- Resistance Level
- ACIU $2.83
- IONR $4.58
- Average True Range (ATR)
- ACIU 0.16
- IONR 0.44
- MACD
- ACIU -0.00
- IONR 0.19
- Stochastic Oscillator
- ACIU 16.85
- IONR 83.11
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About IONR ioneer Ltd
Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.